I-Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4 Ubumsulwa >99.5% EE >99.5%

Incazelo emfushane:

Igama: Boc-3-Hydroxy-1-Adamantyl-D-Glycine

I-CAS: 361442-00-4

Ubumsulwa: >99.5% (GC) EE: >99.5%

Ukubukeka: I-Crystalline Powder Emhlophe noma Engamhlophe

I-Intermediate of API (CAS: 361442-04-8)

E-Mail: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

I-Ruifu Chemical Supply Related Intermediate
I-CAS 361442-04-8
I-CAS 945667-22-1
(R)-1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
I-Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester CAS 361440-67-7
2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7

Chemical Properties:

Igama Lekhemikhali	I-Boc-3-Hydroxy-1-Adamantyl-D-Glycine
Omqondofana	(2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-Hydroxyadamantan-1-yl)i-acetic Acid
Inombolo ye-CAS	361442-00-4
Inombolo yeCAT	I-RF-PI1989
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C17H27NO5
Isisindo samangqamuzana	325.40
Iphuzu elibilayo	497.3±20.0℃
Ukuminyana	1.296
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	I-Crystalline Powder Emhlophe noma Engamhlophe
Amanzi (KF)	<0.50%
Ukulahlekelwa Ekumisweni	<1.00%
Izinsalela ekushiseni	<0.50%
Ukungcola Okukodwa	<0.50%
Ukungcola Okuphelele	<0.50%
EE	>99.5%
Ubumsulwa	>99.5%
I-Infrared Spectrum	Ivumelana Nesakhiwo
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	Pharmaceutical Intermediates

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

I-FAQ:

Isicelo:

I-Boc-3-Hydroxy-1-Adamantyl-D-Glycine (CAS: 361442-00-4) iyi-intermediate ye-API (CAS: 361442-04-8).I-API (CAS: 361442-04-8)iyi-inhibitor enamandla futhi ekhethiwe eguquguqukayo ye-dipeptidyl peptidase-4, eyenzelwe ukwelapha isifo sikashukela sohlobo 2.Imuncwa ngokushesha ngemuva kokuphathwa ngomlomo futhi inephrofayili ye-pharmacokinetic ehambisana nomthamo kanye ngosuku.Kuyi-dipeptidyl peptidase-4 (DPP-4) inhibitor antidiabetic yokwelapha uhlobo 2 sikashukela.I-DPP-4 inhibitors iyikilasi lezinhlanganisela ezisebenza ngokuthinta isenzo samahomoni emvelo emzimbeni abizwa ngokuthi ama-incretin.Itisetshenziswa kanye nokudla kanye nokuzivocavoca ukuthuthukisa ukulawula ushukela wegazi kubantu abadala abanesifo sikashukela sohlobo 2.Akukona okokwelapha isifo sikashukela sohlobo loku-1.Itkwesinye isikhathi isetshenziswa ngokuhlangana neminye imithi yesifo sikashukela.Ifinyelelwe ngokubambisana kwe-AstraZeneca kanye ne-Bristol-Myers Squibb Company futhi ingeye-DPP-IV inhibitor.